All Posts By

Smartkarma Daily Briefs

Daily Brief China: Zijin Mining Group Co Ltd H, ENN Energy, Sany Heavy Industry, Seres Group , Orient Overseas International, 360 Finance, Inc., Hansoh Pharmaceutical Group , BlissBio and more

By | China, Daily Briefs

In today’s briefing:

  • Zijin Mining – Structural Re-Rate Underway; Q3 Results Validate Copper–Gold Flywheel + Spin Unlock
  • Merger Arb Mondays (20 Oct) – ENN Energy, Joy City, Kangji, Mandarin, Soft99, Mandom, Makino
  • Sany Heavy (6031 HK) IPO: Big Cornerstone Allocation to Delay Global Index Inclusion
  • Seres Group H Share Listing: The Investment Case
  • Monthly Container Shipping Tracker | Momentum, Volume Still Weak | Suez Restoration? (October 2025)
  • QFIN US – Follow-Up: Asset-Quality Pressure Undermines Early Bull Case; Recovery Shifts to 2026e
  • Hansoh Pharmaceutical (3692 HK): New Licensing Agreement Asserts R&D Prowess and Pipeline Strength
  • Pre-IPO BlissBio – The Pipeline Has Not yet Been Verified as No Deal Has Been Reached with MNCs


Zijin Mining – Structural Re-Rate Underway; Q3 Results Validate Copper–Gold Flywheel + Spin Unlock

By Rahul Jain

  • Earnings momentum accelerating driven by gold volume +20% and mine margin expansion to 60.6%, supported by disciplined cost control and strong operating cash flow.
  • Copper–gold dual exposure provides structural upside with spot torque to Cu ~US$10,800/t and Au ~US$4,200/oz, reinforcing earnings visibility into FY26–27.
  • Zijin Gold spin-off unlocks value via clean asset separation, improved capital efficiency, and SOTP rerating potential to HK$41–42/sh under spot scenario.


Sany Heavy (6031 HK) IPO: Big Cornerstone Allocation to Delay Global Index Inclusion

By Brian Freitas

  • Sany Heavy Industry (600031 CH) could raise up to HK$16.35bn (US$2.1bn) in its H-share listing if the Offer Size Adjustment Option and the Overallotment Option are both exercised.
  • There is a big allocation to cornerstone investors that is locked up for 6 months. That eliminates the already small possibility of Fast Entry inclusion to global indexes.
  • Sany Heavy (6031 HK) should be added to Southbound Stock Connect from the open of trading on 24 November following the end of the Price Stabilisation period.

Seres Group H Share Listing: The Investment Case

By Arun George

  • Seres Group (601127 CH), a Chinese NEV manufacturer, has filed its PHIP for an H Share listing to raise US$1.5 billion.
  • The A Shares were listed on 15 June 2016. In May 2021 and June 2022, Seres conducted private placements to raise RMB2,567.9 million and RMB7,058.6 million, respectively.
  • The investment case rests on solid NEV performance, improving margin profile and strong cash generation.

Monthly Container Shipping Tracker | Momentum, Volume Still Weak | Suez Restoration? (October 2025)

By Daniel Hellberg

  • Price momentum and volume growth both remained weak in September 
  • Mideast ceasefire raises possibility of Suez Canal re-opening in 2026
  • Expect pricing to remain weak; Suez re-start would likely lead to losses

QFIN US – Follow-Up: Asset-Quality Pressure Undermines Early Bull Case; Recovery Shifts to 2026e

By Raj S, CA, CFA

  • Regulation steady, not softer; policy silence reaffirms the 24% cap as industry standard, with industry participants electing to comply with immediate effect.
  • Asset stress rising; delinquencies peak as low-tier borrowers struggle, but QFIN’s disciplined underwriting and data scale set the stage for recovery in 2026e.
  • Leadership and capital strength, market-leading balance sheet and strong commitment to shareholder returns underpin confidence through the transition phase.

Hansoh Pharmaceutical (3692 HK): New Licensing Agreement Asserts R&D Prowess and Pipeline Strength

By Tina Banerjee

  • Hansoh Pharmaceutical Group (3692 HK) granted Roche an exclusive worldwide license to (excluding the Chinese Mainland, Hong Kong, Macau and Taiwan) to develop, manufacture and commercialize HS-20110.
  • HS-20110 is an investigational CDH17-targeting ADC currently being developed for the treatment of colorectal cancer (CRC) and other tumors, with global Phase I trial underway in China and the US.
  • CDH17 targeted ADCs development (about 31 drug development projects ongoing) scene obviously seems crowded, but Hansoh’s strong execution with Roche’s global prowess will surely give it an edge.

Pre-IPO BlissBio – The Pipeline Has Not yet Been Verified as No Deal Has Been Reached with MNCs

By Xinyao (Criss) Wang

  • The new payload story/ADC-engineering platforms need to be verified by big licensing-out deals. If verification is successful, MNCs will pay high price.However, if verification fails, BlissBio’s pipeline would be “ignored”.
  • BlissBio entered into a wind-down agreement with Eisai for BB-1701.In our view, MNC’s interest in BB-1701 is decreasing.The possibility of reaching big BD deal on BB-1712/BB-1705 is also not high.
  • The investment logic of biotech has changed and high valuation is driven by big licensing-out deals. From this perspective, we think valuation of BlissBio should be lower than peers.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Ganfeng Lithium, Mandarin Oriental International, Samsung Electronics Pref Shares, Kioxia Holdings , Samsung Electronics, Barito Renewables Energy, Zijin Mining Group Co Ltd H, ENN Energy, Sany Heavy Industry and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Ganfeng Lithium (1772 HK): Global Index Inclusion, Outperformance & The A/H Trade
  • Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer
  • Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade
  • Kioxia (285A JP): Toshiba Selling Leads to Passive Buying & Removes Overhang
  • Block Deal Sale of 1.7 Trillion Won Worth of Samsung Electronics
  • Barito Renewables Energy (BREN IJ): Potential Index Inclusion in Nov (Finally?)
  • Zijin Mining – Structural Re-Rate Underway; Q3 Results Validate Copper–Gold Flywheel + Spin Unlock
  • Mandarin Oriental (MAND SP): Matheson’s Full Offer
  • Merger Arb Mondays (20 Oct) – ENN Energy, Joy City, Kangji, Mandarin, Soft99, Mandom, Makino
  • Sany Heavy (6031 HK) IPO: Big Cornerstone Allocation to Delay Global Index Inclusion


Ganfeng Lithium (1772 HK): Global Index Inclusion, Outperformance & The A/H Trade

By Brian Freitas


Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer

By Arun George

  • Mandarin Oriental International (MAND SP) disclosed a privatisation offer from Jardine Matheson Holdings (JM SP) at US$3.35 (US$2.75 cash + US$0.60 special dividend), a 39.6% premium to the last close. 
  • The special dividend represents the majority of the proceeds from the sale of the top thirteen floors of One Causeway Bay (OCB) to Alibaba and Ant Group for US$925 million. 
  • The offer is final. The scheme is conditional on the completion of the OCB sale and Mandarin shareholder approval. This is a done deal due to an attractive offer. 

Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade

By Sanghyun Park

  • Near‑term flow looks muted: Shinhan likely drips ~0.3% SO stake into liquid tape, not a block. With ₩2tn daily turnover, market easily absorbs without price shock.
  • Top‑holder stake dips 20.14→19.84% post‑sale, but ₩10tn buyback cancels ~1.5ppt float, restoring 20.14%. The 0.3% selldown’s pre‑calculated; no real trading juice, flow impact minimal.
  • Inheritance‑tax overhang done, buyback cycle fading. Gov’t pressure plus family’s last selldown point to dividend ramp. Prefs at 23% discount vs 10% target set up clean reversion trade.

Kioxia (285A JP): Toshiba Selling Leads to Passive Buying & Removes Overhang

By Brian Freitas


Block Deal Sale of 1.7 Trillion Won Worth of Samsung Electronics

By Douglas Kim

  • It was reported that Hong Ra-hee, Lee Boo-jin, and Lee Seo-hyun will be selling a combined 1.7 trillion won worth of Samsung Electronics to pay for inheritance taxes.
  • This stake sale by the Lee family will represent 0.3% of Samsung Electronics outstanding shares. 
  • Samsung Electronics still trade at low multiples and its valuations remain attractive. Its recent strategic partnership with OpenAI regarding the Stargate project also remain a major positive catalyst. 

Barito Renewables Energy (BREN IJ): Potential Index Inclusion in Nov (Finally?)

By Brian Freitas

  • Barito Renewables Energy (BREN IJ)‘s stock price has been buffeted by expectations of index inclusion and then an unwind of that positioning a few times over the last year.
  • With selling from some big shareholders, free float appears to have increased to a point where the stock could be added to a global index in November.
  • There is also a possibility of being added to another global index in March, but that is a question for the next year.

Zijin Mining – Structural Re-Rate Underway; Q3 Results Validate Copper–Gold Flywheel + Spin Unlock

By Rahul Jain

  • Earnings momentum accelerating driven by gold volume +20% and mine margin expansion to 60.6%, supported by disciplined cost control and strong operating cash flow.
  • Copper–gold dual exposure provides structural upside with spot torque to Cu ~US$10,800/t and Au ~US$4,200/oz, reinforcing earnings visibility into FY26–27.
  • Zijin Gold spin-off unlocks value via clean asset separation, improved capital efficiency, and SOTP rerating potential to HK$41–42/sh under spot scenario.

Mandarin Oriental (MAND SP): Matheson’s Full Offer

By David Blennerhassett



Sany Heavy (6031 HK) IPO: Big Cornerstone Allocation to Delay Global Index Inclusion

By Brian Freitas

  • Sany Heavy Industry (600031 CH) could raise up to HK$16.35bn (US$2.1bn) in its H-share listing if the Offer Size Adjustment Option and the Overallotment Option are both exercised.
  • There is a big allocation to cornerstone investors that is locked up for 6 months. That eliminates the already small possibility of Fast Entry inclusion to global indexes.
  • Sany Heavy (6031 HK) should be added to Southbound Stock Connect from the open of trading on 24 November following the end of the Price Stabilisation period.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Japan: Kioxia Holdings , Tekscend Photomask, Istyle Inc, Mitsubishi Electric, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Kioxia (285A JP): Toshiba Selling Leads to Passive Buying & Removes Overhang
  • ECM Weekly (20 October 2025)- Sany, Seres, JST, Fibocom, Tekscend, FineToday, LG India, DIY, Duality
  • IStyle: An Omnichannel Benchmark Benefitting from Amazon Shareholding
  • Primer: Mitsubishi Electric (6503 JP) – Oct 2025
  • Election of Foreign Board Directors Is More Critical than % of Female Board Members


Kioxia (285A JP): Toshiba Selling Leads to Passive Buying & Removes Overhang

By Brian Freitas


ECM Weekly (20 October 2025)- Sany, Seres, JST, Fibocom, Tekscend, FineToday, LG India, DIY, Duality

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, India saw a host of listing, while HK is gearing up a busy year end.
  • On the placements front, we had a look at some of the IPO lockups. There weren’t any large placements this week.

IStyle: An Omnichannel Benchmark Benefitting from Amazon Shareholding

By Michael Causton

  • Istyle Inc (3660 JP) is a cosmetics retailer under the name @Cosme, but it is also an exemplar of how to build a true omnichannel business.
  • Its effective use of the deep data available from the 10 million users on its core @Cosme platform is its key asset.
  • It now targets ¥83 billion in sales this year, using data to expand into supplements and Femtech.

Primer: Mitsubishi Electric (6503 JP) – Oct 2025

By αSK

  • Mitsubishi Electric is pivoting its strategic focus towards high-growth digital and green technologies, exemplified by its ‘Serendie’ digital innovation platform and the recent acquisition of cybersecurity firm Nozomi Networks. This is intended to build on its established strengths in factory automation and automotive equipment.
  • The company is targeting significant revenue growth from these new digital ventures, aiming for ¥1.1 trillion from Serendie-related initiatives by FY2031. This strategy is supported by heavy investment in AI and a planned tripling of its digital innovation workforce.
  • While demonstrating strong recent growth and market momentum, the company faces considerable execution risks. These include integrating new acquisitions, competing with established digital platforms from rivals like Siemens and Hitachi, and navigating macroeconomic uncertainties such as currency volatility and potential tariffs.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Election of Foreign Board Directors Is More Critical than % of Female Board Members

By Aki Matsumoto

  • The gradual increase in the proportion of independent directors is partly due to the growing shift from companies with audit committees to companies with audit and supervisory committees.
  • Companies with audit committees tend to have more outside directors by design, yet they can delegate operational matters to inside directors. Consequently, companies don’t strongly resist having more outside directors.
  • As more companies expand businesses globally, the number of foreign directors hasn’t increased significantly. The reason for this lack of growth is the absence of specific targets set by regulators.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: ICICI Prudential Life Insurance and more

By | Daily Briefs, India

In today’s briefing:

  • ICICI Prudential Life (IPRU IN) Vs. ICICI Lombard General (ICICIGI IN): Stat Arb Targeting 5% Return


ICICI Prudential Life (IPRU IN) Vs. ICICI Lombard General (ICICIGI IN): Stat Arb Targeting 5% Return

By Gaudenz Schneider

  • Context: The ICICI Prudential Life (IPRU IN) vs. ICICI Lombard General Insurance (ICICIGI IN) price-ratio has deviated two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long ICICI Prudential Life (IPRU IN) and short ICICI Lombard General Insurance (ICICIGI IN) targets a 5% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: JPX Margin Trading Weekly (Oct 10th): IHI and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • JPX Margin Trading Weekly (Oct 10th): IHI, SoftBank, Fast Retailing, Advantest


JPX Margin Trading Weekly (Oct 10th): IHI, SoftBank, Fast Retailing, Advantest

By Ke Yan, CFA, FRM

  • We analyzed the changes in margin trading positions of JPX stocks as of Oct 10th. The aggregated net margin trading position is USD17,836m.
  • We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
  • We highlight net margin buy/sell changes in IHI, SoftBank, Fast Retailing, Advantest, Mitsubishi Heavy Industries, Keyence, Nojima, Kobe Bussan, Hitachi, Kawasaki Heavy Industries, Ihi, Softbank, Fast Retailing, Advantest.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Rio Tinto Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Rio Tinto: Production in Q3/25 Robust, Metal Price Risks Remain


Rio Tinto: Production in Q3/25 Robust, Metal Price Risks Remain

By Graeme Cunningham

  • The Q3/25 production update was taken well by the market, with iron ore output near flat yoy, copper jumping 10%, and moderate growth for aluminum, alumina and bauxite
  • Some reorganization has started under new CEO Simon Trott, with IOC reported with the core iron ore segment, and two divisions, Borates and Iron and Titanium, placed under review 
  • We see risks from major iron ore market shifts and a potential cyclical downturn hitting copper and aluminum, and it could be fully valued on our below-consensus metal price estimates 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer
  • Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade
  • Sammaan Capital: Can Capital Boost from Abu Dhabi Turnaround Its Fortunes?
  • Last Week In Event SPACE: Hang Seng, Welcia/Tsuruha, HKT, Genting, Daiichi, Aussie Rare Earths
  • (Mostly) Asia-Pac M&A: Mandarin Oriental, RPMGlobal, Genting, Mayne Pharma, Iress, Kangji Medical


Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer

By Arun George

  • Mandarin Oriental International (MAND SP) disclosed a privatisation offer from Jardine Matheson Holdings (JM SP) at US$3.35 (US$2.75 cash + US$0.60 special dividend), a 39.6% premium to the last close. 
  • The special dividend represents the majority of the proceeds from the sale of the top thirteen floors of One Causeway Bay (OCB) to Alibaba and Ant Group for US$925 million. 
  • The offer is final. The scheme is conditional on the completion of the OCB sale and Mandarin shareholder approval. This is a done deal due to an attractive offer. 

Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade

By Sanghyun Park

  • Near‑term flow looks muted: Shinhan likely drips ~0.3% SO stake into liquid tape, not a block. With ₩2tn daily turnover, market easily absorbs without price shock.
  • Top‑holder stake dips 20.14→19.84% post‑sale, but ₩10tn buyback cancels ~1.5ppt float, restoring 20.14%. The 0.3% selldown’s pre‑calculated; no real trading juice, flow impact minimal.
  • Inheritance‑tax overhang done, buyback cycle fading. Gov’t pressure plus family’s last selldown point to dividend ramp. Prefs at 23% discount vs 10% target set up clean reversion trade.

Sammaan Capital: Can Capital Boost from Abu Dhabi Turnaround Its Fortunes?

By Himanshu Dugar

  • Sammaan Capital approved a 3-part preferential issue to Avenir, part of Abu Dhabi’s sovereign-controlled IHC, aggregating INR 8,850 crore (USD 1.06 billion) in equity and warrants (convertible in 18 months)
  • Sammaan has been looking out for an equity partner for few quarters now. Avenir’s backing not just improves capital positioning but also helps restructure overall liability side of the business
  • Upon consummation (80% probability), we anticipate material re-rating potential. However, there are multiple risks in the near term, including accelerated write-offs. Further, an ongoing litigation may jeopardize the deal itself.

Last Week In Event SPACE: Hang Seng, Welcia/Tsuruha, HKT, Genting, Daiichi, Aussie Rare Earths

By David Blennerhassett


(Mostly) Asia-Pac M&A: Mandarin Oriental, RPMGlobal, Genting, Mayne Pharma, Iress, Kangji Medical

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Mandarin Oriental International and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer
  • Mandarin Oriental: Good Deal for Jardine, Not So Much for Mandarin Oriental Minorities


Mandarin Oriental (MAND SP): Jardine Matheson’s Attractive Scheme Offer

By Arun George

  • Mandarin Oriental International (MAND SP) disclosed a privatisation offer from Jardine Matheson Holdings (JM SP) at US$3.35 (US$2.75 cash + US$0.60 special dividend), a 39.6% premium to the last close. 
  • The special dividend represents the majority of the proceeds from the sale of the top thirteen floors of One Causeway Bay (OCB) to Alibaba and Ant Group for US$925 million. 
  • The offer is final. The scheme is conditional on the completion of the OCB sale and Mandarin shareholder approval. This is a done deal due to an attractive offer. 

Mandarin Oriental: Good Deal for Jardine, Not So Much for Mandarin Oriental Minorities

By Nicolas Van Broekhoven


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: BillionToOne and more

By | Daily Briefs, ECM

In today’s briefing:

  • BillionToOne, Inc (BLLN): Peeking at the IPO Prospectus of a Precision Diagnostics Company
  • Evommune Inc. (EVMN): Peeking at the IPO Prospectus of a Chronic Inflammatory Biotech Company
  • BillionToOne IPO (BLLN.US): Unique Financial Profile For Molecular Diagnostics Company, Strong Buy


BillionToOne, Inc (BLLN): Peeking at the IPO Prospectus of a Precision Diagnostics Company

By IPO Boutique

  • Their revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity.
  • For the year ended December 31, 2024, they generated revenue of $152.6 million, representing 113% year-over-year growth, with a gross margin of 53% and net loss of $41.6 million.
  • BillionToOne has raised nearly $400 million in equity funding prior to its IPO, complemented by debt financing, and continues to innovate within prenatal, oncology, and rare disease testing markets. 

Evommune Inc. (EVMN): Peeking at the IPO Prospectus of a Chronic Inflammatory Biotech Company

By IPO Boutique

  • Evommune is a clinical-stage biotechnology company focused on developing therapies for chronic inflammatory diseases.
  • Their most advanced clinical-stage product candidate, EVO756, is a potent and highly selective oral small molecule antagonist of MRGPRX2, a receptor predominantly found on mast cells and peripheral sensory neurons.
  • The company is backed by many well-known sector dedicated investors including RA Capital. 

BillionToOne IPO (BLLN.US): Unique Financial Profile For Molecular Diagnostics Company, Strong Buy

By Andrei Zakharov

  • BillionToOne Inc., a fastest-growing healthtech unicorn in the prenatal and oncology testing market in the U.S., set terms for its US IPO.
  • The California-based molecular diagnostics company posts hyper-growth and enjoys industry-leading gross margins. Positive non-GAAP op income is likely to be achieved in 2025.
  • BillionToOne Inc. has delivered 3+ years of exceptional revenue growth with a +167% CAGR over the past three years and strong gross margin profile supporting emerging profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Samsung Electronics Pref Shares, ESR Kendall Square REIT and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade
  • SHORT ESR Kendall Square REIT: Korea Logistics Oversupply & K-REIT Funding


Final Samsung Electronics Stake Sale: Overhang Risk, Control Optics, & Clean Pref Reversion Trade

By Sanghyun Park

  • Near‑term flow looks muted: Shinhan likely drips ~0.3% SO stake into liquid tape, not a block. With ₩2tn daily turnover, market easily absorbs without price shock.
  • Top‑holder stake dips 20.14→19.84% post‑sale, but ₩10tn buyback cancels ~1.5ppt float, restoring 20.14%. The 0.3% selldown’s pre‑calculated; no real trading juice, flow impact minimal.
  • Inheritance‑tax overhang done, buyback cycle fading. Gov’t pressure plus family’s last selldown point to dividend ramp. Prefs at 23% discount vs 10% target set up clean reversion trade.

SHORT ESR Kendall Square REIT: Korea Logistics Oversupply & K-REIT Funding

By Jacob Cheng

  • Despite having strong operational performances, we think ESR KS REIT is currently facing 2 headwinds, 1 structural issue and 1 cyclical issue
  • Korea listed companies are generally suffering from under-valuation and excessive equity raise.  The equity raises, which are done at discount to NAV, is value destructive
  • In the physical market, we think the logistics market is facing oversupply issue, slow absorption and protected recovery.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars